TLR4 and Alzheimer disease: We thus concluded that endothelial Aβ accumulation may contribute to a vascular proinflammatory status while inhibiting TLR4‐mediated inflammation could reverse Aβ‐induced alterations and serve as a potential therapeutic target for CAA/AD treatment.